LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (HK:2291) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. has announced that its subsidiary has received a medical device registration certificate from China’s National Medical Products Administration for its innovative MemoSorb Biodegradable Atrial Septal Defect Occluder Product. The new device promises to offer superior biocompatibility and long-term health benefits for patients with congenital heart disease over traditional metal occluders. The company anticipates this will expand their market opportunities and contribute to the global healthcare industry, though they acknowledge the financial impact of the product remains uncertain.
For further insights into HK:2291 stock, check out TipRanks’ Stock Analysis page.